Episode Details

India is getting fatter, sicker and more diabetic every year.And now, one injection promises to change everything.GLP-1 drugs like Ozempic are being called a medical breakthrough. They can reduce appetite, accelerate weight loss and help patients control obesity and diabetes.But critics believe these drugs could become a capitalist disaster. One that profits from unhealthy lifestyles while exposing millions of Indians to risks we still do not fully understand.So, is Ozempic a miracle drug or a dangerous shortcut?On one side is Jitendra Chouksey, Founder of FITTR. He believes obesity must primarily be tackled through lifestyle changes and questions the safety, regulation and long-term use of GLP-1 drugs.On the other side are Dr Muffazal Lakdawala, one of India’s leading bariatric surgeons, and Arjun Garewal, a fitness consultant. They believe GLP-1 can transform lives when prescribed to the right patients and combined with proper nutrition, exercise and medical supervision.One drug. Two opposing sides. A decision that could affect millions of Indians.Miracle or disaster? Watch the debate and decide for yourself!